Evidence map›Paper›PMID 35533977›Full record

SynthesisAnaesthesia, critical care & pain medicine2022

Solid organ transplantation from donors with recent or current SARS-CoV-2 infection: A systematic review.

Raquel Martinez-Reviejo, Sofia Tejada, Ana Cipriano, Hanife Nur Karakoc, Oriol Manuel, Jordi Rello

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Anaesthesia, critical care & pain medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Therapeutic strategy in the transplanted patient.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023
    Review
  8. Review
  9. Review
  10. Review
  11. COVID-19 in donation and transplant.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2022
    Review
  12. Donor Evaluation Protocol for Live and Deceased Donors.Journal of clinical and experimental hepatology
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 4 countries.

Raquel Martinez-ReviejoClinical Research/Epidemiology in Pneumonia & Sepsis (CRIPS), Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain; Centro de Investigación Biomédica En Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Sofia TejadaClinical Research/Epidemiology in Pneumonia & Sepsis (CRIPS), Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain; Centro de Investigación Biomédica En Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: stmagraner@gmail.com.
Ana CiprianoInfectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Hanife Nur KarakocKaradeniz Technical University School of Medicine, Trabzon, Turkey.
Oriol ManuelInfectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; Transplantation Centre, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Jordi RelloClinical Research/Epidemiology in Pneumonia & Sepsis (CRIPS), Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain; Centro de Investigación Biomédica En Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain; Department of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain; Clinical Research, CHRU Nimes, Nimes, France.
Instituto de Salud Carlos III · ESUniversity of Lausanne · CHKaradeniz Technical University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSolid-organ transplantation (SOT) from SARS-CoV-2 positive donors could be a life-saving opportunity worth grasping. We perform a systematic review to evaluate the recipient outcomes of SOT from donors with recent or current SARS-CoV-2 infection.

methodsSearch strategy was performed in PubMed, Cochrane COVID-19 Study Register, and Web of Science databases from the 1

conclusionUse of non-lung (kidney, liver and heart) organs from SARS-CoV-2 positive donors seem to be a safe practice, with a low risk of transmission irrespective of the presence of symptoms at the time of procurement. Low viral replication (Ct > 30) was safe among non-lung donors, even if persistently symptomatic at procurement.

Indexed as

COVID-19Organ TransplantationAdultHumansRNA, ViralSARS-CoV-2Tissue DonorsRNA, ViralCOVID-19Organ donationSolid organ transplantationViral transmission

Identifiers

PMID35533977
PMCPMC9074299
OpenAlexW4229019957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.